AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 259: F598-F604, 1990;
0363-6127/90 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dworkin, L. D.
Right arrow Articles by Feiner, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dworkin, L. D.
Right arrow Articles by Feiner, H. D.

AJP - Renal Physiology, Vol 259, Issue 4 598-F604, Copyright © 1990 by American Physiological Society

ARTICLES

Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension

L. D. Dworkin, R. I. Levin, J. A. Benstein, M. Parker, M. E. Ullian, Y. Kim and H. D. Feiner
Department of Medicine, New York University Medical Center, New York 10016.

Male Munich-Wistar rats underwent right nephrectomy and were given weekly injections of deoxycorticosterone acetate (DOCA) and 1% saline (salt) to drink. Two studies were performed. In the first, rats given enalapril (ENP) were compared with controls. In the second, rats ingested either standard chow or chow to which the calcium-entry blocker nifedipine (NIF) had been added. Six to eight weeks after nephrectomy, both control DOCA-salt rats and those given ENP had severe hypertension and significant proteinuria. Rats given NIF excreted less protein, and glomerular lesions were not observed in this group. The effects of NIF on several parameters that have been associated with glomerular injury were examined. Micropuncture studies revealed that glomerular capillary pressure was increased in DOCA-salt rats and was not reduced by NIF. Platelet aggregation was also similar in NIF-treated and control rats. Morphometric studies revealed a tendency toward lower glomerular volume of NIF-treated rats; however, kidney weight and glomerular capillary radius were unaffected by therapy. Thus NIF, but not ENP, prevents DOCA-salt rats from developing hypertension and glomerular injury. This effect does not depend on reduction in glomerular pressure or inhibition of platelet aggregation.


This article has been cited by other articles:


Home page
 HypertensionHome page
K. Skov, J. Fenger-Gron, and M. J. Mulvany
Effects of an Angiotensin-Converting Enzyme Inhibitor, a Calcium Antagonist, and an Endothelin Receptor Antagonist on Renal Afferent Arteriolar Structure
Hypertension, September 1, 1996; 28(3): 464 - 471.
[Abstract] [Full Text]

Home page
 HypertensionHome page
L. D. Dworkin, E. Tolbert, P. A. Recht, J. C. Hersch, H. Feiner, and R. I. Levin
Effects of Amlodipine on Glomerular Filtration, Growth, and Injury in Experimental Hypertension
Hypertension, February 1, 1996; 27(2): 245 - 250.
[Abstract] [Full Text]

Home page
 HypertensionHome page
M. O. Ribeiro, E. Antunes, M. N. Muscara, G. De Nucci, and R. Zatz
Nifedipine Prevents Renal Injury in Rats With Chronic Nitric Oxide Inhibition
Hypertension, July 1, 1995; 26(1): 150 - 155.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online